Literature DB >> 31396699

Guidelines for the screening and diagnosis of gestational diabetes in Italy from 2010 to 2019: critical issues and the potential for improvement.

Ester Vitacolonna1,2,3, Elena Succurro4,5,6, Annunziata Lapolla4,5,7, Marina Scavini4,5,8, Matteo Bonomo4,5,9, Graziano Di Cianni4,5,10, Antonino Di Benedetto4,5,11, Angela Napoli4,5,12, Andrea Tumminia4,5,13, Camilla Festa4,5,12, Cristina Lencioni4,5,14, Elisabetta Torlone4,5,15, Giorgio Sesti6,16, Domenico Mannino4,5,17,18, Francesco Purrello13,19.   

Abstract

AIMS: In 2010, Italian health professionals rapidly implemented the one-step screening for gestational diabetes mellitus (GDM) based on a 75 g OGTT, to comply with the diagnostic criteria proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG). The change was promoted by the two main Italian scientific societies of diabetology, Associazione Medici Diabetologi (AMD) and Società Italiana di Diabetologia (SID), and it took just a few months for the Istituto Superiore di Sanità, together with several scientific societies, to revise the criteria and include them in the National Guidelines System. Over the last 9 years, the implementation of these guidelines has shown some benefits and some drawbacks.
METHODS: In order to evaluate the critical issues arisen from the implementation of the current Italian guidelines for the diagnosis of GDM, the studies published on this topic have been reviewed. The search was performed using the following keywords: "gestational diabetes" AND "diagnostic criteria" OR screening AND Ital*. The study is an expert opinion paper, based on the relevant scientific literature published between 2010 and 2019. The databases screened for the literature review included PubMed, MEDLINE, and Scopus.
RESULTS: The implementation of the Guidelines for Screening and Diagnosis of GDM in Italy present some strengths and some weaknesses. One of the positive aspects is that high-risk women are required to perform an OGTT early in pregnancy. By contrast, there are several aspects in need of improvement: (1) In spite of the current indications, only a minority of high-risk women perform OGTT early in pregnancy; (2) several low-risk women are screened for GDM; (3) in some low-risk women affected by GDM, the diagnosis might be missed with the application of the current guidelines; (4) there is a lack of homogeneity in the risk assessment data from different regions.
CONCLUSIONS: In order to improve the current Italian GDM guidelines, some practical solutions have been suggested.

Entities:  

Keywords:  Diagnostic criteria; Fetal outcomes; Gestational diabetes; Macrosomia; Maternal outcomes; Non-communicable diseases; Obesity prevention

Mesh:

Year:  2019        PMID: 31396699     DOI: 10.1007/s00592-019-01397-4

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  6 in total

1.  Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.

Authors:  Mildren A Del-Sueldo; María A Mendonça-Rivera; Martha B Sánchez-Zambrano; Judith Zilberman; Ana G Múnera-Echeverri; María Paniagua; Lourdes Campos-Alcántara; Claudia Almonte; Amalia Paix-Gonzales; Claudia V Anchique-Santos; Claudine J Coronel; Gabriela Castillo; María G Parra-Machuca; Ivanna Duro; Paola Varletta; Patricia Delgado; Verónica I Volberg; Adriana C Puente-Barragán; Adriana Rodríguez; Aida Rotta-Rotta; Anabela Fernández; Ana C Izeta-Gutiérrez; Ana E Ancona-Vadillo; Analía Aquieri; Andrea Corrales; Andrea Simeone; Bibiana Rubilar; Carolina Artucio; Carolina Pimentel-Fernández; Celi Marques-Santos; Clara Saldarriaga; Christian Chávez; Cristina Cáceres; Dahiana Ibarrola; Daniela Barranco; Edison Muñoz-Ortiz; Edith D Ruiz-Gastelum; Eduardo Bianco; Elena Murguía; Enrique Soto; Fabiola Rodríguez-Caballero; Fanny Otiniano-Costa; Giovanna Valentino; Iris B Rodríguez-Cermeño; Ivan R Rivera; Jairo A Gándara-Ricardo; Jesús A Velásquez-Penagos; Judith Torales; Karina Scavenius; Karen Dueñas-Criado; Laura García; Laura Roballo; Lucía R Kazelian; Macarena Coussirat-Liendo; María C Costa-Almeida; Mariana Drever; Mariela Lujambio; Marildes L Castro; Maritza Rodríguez-Sifuentes; Mónica Acevedo; Mónica Giambruno; Mónica Ramírez; Nancy Gómez; Narcisa Gutiérrez-Castillo; Onelia Greatty; Paola Harwicz; Patricia Notaro; Rocío Falcón; Rosario López; Sady Montefilpo; Sara Ramírez-Flores; Silvina Verdugo; Soledad Murguía; Sonia Constantini; Thais C Vieira; Virginia Michelis; César M Serra
Journal:  Arch Cardiol Mex       Date:  2022

2.  Fat mass and obesity-associated (FTO) gene epigenetic modifications in gestational diabetes: new insights and possible pathophysiological connections.

Authors:  Marica Franzago; Federica Fraticelli; Michele Marchioni; Marta Di Nicola; Francesca Di Sebastiano; Marco Liberati; Liborio Stuppia; Ester Vitacolonna
Journal:  Acta Diabetol       Date:  2021-03-20       Impact factor: 4.280

3.  Osteoprotegerin, interleukin and hepatocyte growth factor for prediction of diabetes and hypertension in the third trimester of pregnancy.

Authors:  Su-Jing Huang; Hong-Wei Wang; Hai-Fang Wu; Qiu-Yuan Wei; Shu Luo; Lin Xu; Hong-Qiong Guan
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

Review 4.  Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions.

Authors:  Antonio Aversa; Sandro La Vignera; Rocco Rago; Alessandra Gambineri; Rossella E Nappi; Aldo E Calogero; Alberto Ferlin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

Review 5.  Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes.

Authors:  Emilyn U Alejandro; Therriz P Mamerto; Grace Chung; Adrian Villavieja; Nawirah Lumna Gaus; Elizabeth Morgan; Maria Ruth B Pineda-Cortel
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

6.  Continuous Glucose Monitoring in Women with Normal OGTT in Pregnancy.

Authors:  Linda Tartaglione; Enrico di Stasio; Angelo Sirico; Mauro Di Leo; Salvatore Caputo; Alessandro Rizzi; Agnese Caneschi; Sara De Carolis; Dario Pitocco; Antonio Lanzone
Journal:  J Diabetes Res       Date:  2021-08-23       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.